Categories Articles Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report? Post author By crystalg Post date November 11, 2022 Entrepreneur: Latest Articles Tags 'blowout', After, Biosciences, midcap, Neurocrine, Report ← The government’s done a deep-dive on how consumers have been hurt by crypto → Warren Buffett’s Berkshire Hathaway reveals it sold about $4 billion of US Bancorp stock – and likely scored a $600 million profit